Sources | Names Used |
---|---|
CTRPv2 | BRD-K42260513 |
PharmacoGx | BRD-K42260513 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKA2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
mRNA | EXOC3L1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
mRNA | AHRR | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
mRNA | GATAD2A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
mRNA | AP5B1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
mRNA | SPATS2L | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |
mRNA | PCDHGB1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
mRNA | RP11-404P21.8 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.1 |
mRNA | FAF1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
mRNA | PCDHGA6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |